The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...

This protein from tardigrades may hold the key to protecting healthy tissues during cancer radiation treatment.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...

IPA's strategy melds AI-driven analytics with specialised wet-lab methodologies to design and optimise antibodies.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...